Table 3. Patient Global Ratings.

Rating Scale	No. (%)			P Valuea
	Behavioral Therapy	Drug Therapy	Combined Therapy
After 6-wk Follow-up (Stage 1)
Total, No.	64	65	61	NA
Global perception of improvement
Much better	13 (20)	9 (14)	24 (39)	<.001
Better	39 (61)	33 (51)	31 (51)
About the same	12 (19)	22 (34)	6 (10)
Worse	0	1 (2)	0
Satisfaction with progress
Completely	18 (28)	13 (20)	30 (49)	<.001
Somewhat satisfied	42 (66)	41 (63)	30 (49)
Somewhat dissatisfied	3 (5)	8 (12)	1 (2)
Very dissatisfied	1 (2)	3 (5)	0
How bothersome were adverse effects?
No adverse effects	33 (52)	12 (18)	8 (13)	<.001
Not at all bothersome	22 (34)	9 (14)	13 (21)
A little	6 (9)	20 (31)	29 (48)
Somewhat	3 (5)	18 (28)	10 (16)
Extremely	0	6 (9)	1 (2)
Wish to receive another form of treatment	44 (69)	38 (58)	27 (44)	.02
After 12-wk Follow-up (Stage 2)
Total, No.	62	61	59	NA
Global perception of improvement
Much better	28 (45)	26 (43)	30 (51)	.32
Better	27 (43)	26 (43)	26 (44)
About the same	5 (8)	9 (15)	3 (5)
Worse	2 (3)	0	0
Satisfaction with progress
Completely	32 (52)	32 (52)	28 (47)	.82
Somewhat satisfied	26 (42)	28 (46)	29 (49)
Somewhat dissatisfied	3 (5)	0	1 (2)
Very dissatisfied	1 (2)	1 (2)	1 (2)
How bothersome were adverse effects?
No adverse effects	13 (21)	9 (15)	12 (20)	.55
Not at all bothersome	17 (27)	12 (20)	10 (17)
A little	16 (26)	27 (44)	16 (27)
Somewhat	14 (23)	12 (20)	19 (32)
Extremely	2 (3)	1 (2)	2 (3)
Wish to receive another form of treatment	23 (37)	20 (33)	16 (27)	.50

Abbreviation: NA, not applicable.

^aCochran-Mantel-Haenszel procedure used to account to the ordinal nature of response.